202 related articles for article (PubMed ID: 25353306)
1. Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments.
Miranda R; MacKillop J; Treloar H; Blanchard A; Tidey JW; Swift RM; Chun T; Rohsenow DJ; Monti PM
Addict Biol; 2016 Jan; 21(1):171-82. PubMed ID: 25353306
[TBL] [Abstract][Full Text] [Related]
2. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.
Miranda R; MacKillop J; Monti PM; Rohsenow DJ; Tidey J; Gwaltney C; Swift R; Ray L; McGeary J
Alcohol Clin Exp Res; 2008 Mar; 32(3):489-97. PubMed ID: 18215213
[TBL] [Abstract][Full Text] [Related]
3. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
Wetherill RR; Spilka N; Jagannathan K; Morris P; Romer D; Pond T; Lynch KG; Franklin TR; Kranzler HR
Neuropsychopharmacology; 2021 Jul; 46(8):1414-1420. PubMed ID: 33558678
[TBL] [Abstract][Full Text] [Related]
4. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
5. GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink.
Kranzler HR; Armeli S; Feinn R; Tennen H; Gelernter J; Covault J
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1549-56. PubMed ID: 24786948
[TBL] [Abstract][Full Text] [Related]
6. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.
Batki SL; Pennington DL; Lasher B; Neylan TC; Metzler T; Waldrop A; Delucchi K; Herbst E
Alcohol Clin Exp Res; 2014 Aug; 38(8):2169-77. PubMed ID: 25092377
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
[TBL] [Abstract][Full Text] [Related]
8. Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Haass-Koffler CL; Goodyear K; Zywiak WH; Leggio L; Kenna GA; Swift RM
Alcohol Alcohol; 2018 May; 53(3):268-276. PubMed ID: 29281033
[TBL] [Abstract][Full Text] [Related]
9. Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care.
Feinn R; Curtis B; Kranzler HR
J Clin Psychiatry; 2016 Mar; 77(3):e278-82. PubMed ID: 26891181
[TBL] [Abstract][Full Text] [Related]
10. A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.
Pennington DL; Bielenberg J; Lasher B; Herbst E; Abrams G; Novakovic-Agopian T; Batki SL
Drug Alcohol Depend; 2020 Sep; 214():108149. PubMed ID: 32712569
[TBL] [Abstract][Full Text] [Related]
11. Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.
Johnson BA; Roache JD; Ait-Daoud N; Gunderson EW; Haughey HM; Wang XQ; Liu L
Addict Biol; 2013 May; 18(3):405-16. PubMed ID: 23039088
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.
Krishnan-Sarin S; O'Malley SS; Franco N; Cavallo DA; Morean M; Shi J; Pittman B; Krystal JH
Alcohol Clin Exp Res; 2015 Feb; 39(2):300-7. PubMed ID: 25664775
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
14. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.
Isgro M; Doran N; Heffner JL; Wong E; Dinh E; Tibbs J; Russell K; Bittner T; Wehrle C; Worley MJ; Anthenelli RM
J Stud Alcohol Drugs; 2017 Mar; 78(2):232-240. PubMed ID: 28317503
[TBL] [Abstract][Full Text] [Related]
15. GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate.
Kranzler HR; Armeli S; Tennen H; Gelernter J; Covault J
Exp Clin Psychopharmacol; 2014 Dec; 22(6):494-501. PubMed ID: 25436841
[TBL] [Abstract][Full Text] [Related]
16. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
Roberts W; Harrison ELR; McKee SA
Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
[TBL] [Abstract][Full Text] [Related]
17. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Kranzler HR; Covault J; Feinn R; Armeli S; Tennen H; Arias AJ; Gelernter J; Pond T; Oncken C; Kampman KM
Am J Psychiatry; 2014 Apr; 171(4):445-52. PubMed ID: 24525690
[TBL] [Abstract][Full Text] [Related]
18. Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.
Paparrigopoulos T; Tzavellas E; Karaiskos D; Kourlaba G; Liappas I
BMC Psychiatry; 2011 Mar; 11():41. PubMed ID: 21401921
[TBL] [Abstract][Full Text] [Related]
19. Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.
Miranda R; Treloar Padovano H; Gray JC; Wemm SE; Blanchard A
Addict Behav; 2018 Aug; 83():72-78. PubMed ID: 29395188
[TBL] [Abstract][Full Text] [Related]
20. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
